SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $215,208 | +829.8% | 600,637 | +1639.2% | 0.00% | – |
Q1 2024 | $23,146 | -69.1% | 34,536 | -75.0% | 0.00% | – |
Q4 2023 | $74,996 | -91.3% | 138,038 | -79.2% | 0.00% | – |
Q2 2023 | $864,115 | +61.2% | 664,704 | +507.8% | 0.00% | – |
Q3 2022 | $536,000 | +46.4% | 109,356 | +23.9% | 0.00% | – |
Q2 2022 | $366,000 | -56.1% | 88,241 | -38.5% | 0.00% | – |
Q1 2022 | $833,000 | -53.2% | 143,573 | -39.5% | 0.00% | – |
Q4 2021 | $1,779,000 | +68.6% | 237,133 | +102.5% | 0.00% | – |
Q3 2021 | $1,055,000 | -48.9% | 117,096 | -32.1% | 0.00% | – |
Q2 2021 | $2,065,000 | -29.3% | 172,521 | -25.9% | 0.00% | -100.0% |
Q1 2021 | $2,919,000 | -73.1% | 232,938 | -66.5% | 0.00% | -80.0% |
Q4 2020 | $10,856,000 | +171.9% | 695,634 | +64.6% | 0.01% | +150.0% |
Q3 2020 | $3,993,000 | +29.4% | 422,660 | +22.7% | 0.00% | 0.0% |
Q2 2020 | $3,086,000 | +939.1% | 344,486 | +640.1% | 0.00% | – |
Q1 2020 | $297,000 | +194.1% | 46,546 | +287.2% | 0.00% | – |
Q4 2019 | $101,000 | -69.4% | 12,021 | -67.0% | 0.00% | -100.0% |
Q3 2019 | $330,000 | -23.8% | 36,441 | -19.8% | 0.00% | 0.0% |
Q1 2019 | $433,000 | -2.7% | 45,450 | +17.1% | 0.00% | 0.0% |
Q4 2018 | $445,000 | -55.3% | 38,827 | -33.8% | 0.00% | -50.0% |
Q3 2018 | $995,000 | +159.8% | 58,691 | +117.4% | 0.00% | +100.0% |
Q2 2018 | $383,000 | -75.2% | 27,000 | -66.8% | 0.00% | -75.0% |
Q1 2018 | $1,545,000 | +160.5% | 81,322 | +124.9% | 0.00% | +100.0% |
Q4 2017 | $593,000 | -5.0% | 36,155 | -13.1% | 0.00% | 0.0% |
Q3 2017 | $624,000 | +280.5% | 41,591 | +53.1% | 0.00% | +100.0% |
Q1 2016 | $164,000 | +0.6% | 27,160 | +52.6% | 0.00% | 0.0% |
Q4 2015 | $163,000 | -58.5% | 17,800 | -49.7% | 0.00% | -66.7% |
Q2 2015 | $393,000 | -40.1% | 35,393 | -17.9% | 0.00% | -40.0% |
Q4 2014 | $656,000 | +507.4% | 43,107 | +331.1% | 0.01% | +400.0% |
Q3 2014 | $108,000 | -47.3% | 10,000 | -25.6% | 0.00% | -66.7% |
Q2 2014 | $205,000 | – | 13,443 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
EMC Capital Management | 72,061 | $903,000 | 0.64% |
WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |